glp-1 agonist or antagonist Frontiers

Glucagon like peptide 1 (GLP 1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment ScienceDirect Novo Nordisk's oral GLP 1 drug didn't work on Alzheimer's as hoped, but don't call it a failure MarketWatch A new, higherdose version of the GLP1 drug Wegovy is set to hit the market. Lara Spencer has the details. CrazyLeaf Nano Microneedle Patch Exposed: WeightLoss Scam? GLP1 receptor agonists are supported by preclinical and observational evidence for reducing addictive behaviors, particularly alcohol and nicotine use. Initial randomized clinical trials indicate possible reductions in craving and substance intake, though A narrative review of glucagon like peptide 1 receptor agonists prior to deep sedation or general anesthesia Journal of Anesthesia, Analgesia and Critical Care Springer Nature Link